| Mrs Afaf Guirguis Karanany, RPH | |
|
4044 Eagle Rock Blvd, Los Angeles, CA 90065-3608 | |
| (323) 254-8642 | |
| Not Available |
| Full Name | Mrs Afaf Guirguis Karanany |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4044 Eagle Rock Blvd, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003137555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 53481 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Afaf Guirguis Karanany, RPH 4044 Eagle Rock Blvd, Los Angeles, CA 90065-3608 Ph: (323) 254-8642 | Mrs Afaf Guirguis Karanany, RPH 4044 Eagle Rock Blvd, Los Angeles, CA 90065-3608 Ph: (323) 254-8642 |
News Archive
While most malaria research has focused on the parasite Plasmodium falciparum, which is common in Africa, another parasite, Plasmodium vivax (P.vivax) is responsible for the majority of malaria infections outside this region, causing an estimated 15.8 million clinical malaria cases each year.
An artificial mimic of a key light-sensitive molecule has been made by scientists at the University of Bristol. The work, published in Science, could lead to new ways of building light-sensitive artificial cells.
New York Times reporter Lawrence Altman recounts his experience in the mid-1960s with a measles immunization campaign in Upper Volta during his time with the Epidemic Intelligence Service of the CDC in a "Doctor's World" perspective piece in the newspaper. Altman says that although the effort to expand the immunization campaign from a small field trial to a regional program "failed miserably," the "lessons learned from these blunders led to a new program that wiped out smallpox, still the only human disease to have been eradicated from the planet."
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced dosing of the first patient with CRMD-001 (a proprietary formulation of deferiprone) in a randomized, double-blind, placebo-controlled clinical trial.
The report, published in the prestigious international journal, the British Journal of Obstetrics and Gynaecology, found that the rise could not be explained by increases in clinical reasons for caesareans such as complications in pregnancy or labour/delivery and was more likely due to societal factors.
› Verified 8 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |